FDA Drug Application (021959) for ORAPRED ODT by CONCORDIA PHARMS INC

Back to FDA Applications sponsored by CONCORDIA PHARMS INC

Application Number021959
Product Number001
FormTABLET, ORALLY DISINTEGRATING;ORAL
DosageEQ 10MG BASE
Product Market Status Prescription
Therapeutic Equivalence Evaluation Code AB Products meeting necessary bioequivalence requirements
Reference Drug
Drug NameORAPRED ODT
Active IngredientPREDNISOLONE SODIUM PHOSPHATE

Active IngredientCount
List of drugs with Active Ingredient PREDNISOLONE SODIUM PHOSPHATE14


Back to FDA Applications sponsored by CONCORDIA PHARMS INC